| Primary |
| Schizophrenia |
38.8% |
| Product Used For Unknown Indication |
20.0% |
| Schizoaffective Disorder |
5.0% |
| Arthritis |
3.8% |
| Depression |
3.8% |
| Anxiety |
2.5% |
| Behavioural And Psychiatric Symptoms Of Dementia |
2.5% |
| Bipolar Disorder |
2.5% |
| Blood Cholesterol Increased |
2.5% |
| Diabetes Mellitus |
2.5% |
| Insomnia |
2.5% |
| Schizophrenia, Paranoid Type |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
| Affective Disorder |
1.3% |
| Constipation |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Major Depression |
1.3% |
| Mood Altered |
1.3% |
| Obsessive-compulsive Disorder |
1.3% |
| Parkinsonism |
1.3% |
|
| Sedation |
20.0% |
| Somnolence |
11.4% |
| Feeling Drunk |
8.6% |
| Speech Disorder |
8.6% |
| Depression |
5.7% |
| Tremor |
5.7% |
| Abscess |
2.9% |
| Death |
2.9% |
| Delirium |
2.9% |
| Disorientation |
2.9% |
| Hallucination |
2.9% |
| Hypotension |
2.9% |
| Injection Site Abscess |
2.9% |
| Metabolic Syndrome |
2.9% |
| Nausea |
2.9% |
| Overdose |
2.9% |
| Platelet Count Decreased |
2.9% |
| Prescribed Overdose |
2.9% |
| Pulmonary Embolism |
2.9% |
| Sensation Of Foreign Body |
2.9% |
|
